Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Recombinant interleukin 2 stimulates in vivo proliferation of adoptively transferred lymphokine-activated killer (LAK) cells

Journal Article · · J. Immunol.; (United States)
OSTI ID:6235249

The authors previously reported that the adoptive transfer of lymphokine-activated killer (LAK) cells plus repetitive injections of recombinant interleukin 2 (IL 2) produced a marked reduction in established pulmonary metastases from a variety of murine sarcomas. The requirement for the exogenous administration of IL 2 prompted a subsequent examination of the role of IL 2 in the in vivo function of transferred LAK cells. The in vivo proliferation and migration patterns of lymphoid cells in C57BL/6 mice were examined after i.v. transfer of LAK cells alone, i.p. injection of IL 2 alone, or the combination of LAK cells and IL 2. A model for in vivo labeling of the DNA of dividing cells was used in which mice were injected with 5-( SVI)-iodo-2'-deoxyuridine ( SVIUdR) and, 20 hr later, their tissues were removed and were counted in a gamma analyzer. A proliferation index (PI) was calculated by dividing the mean cpm of organs of experimentally treated mice by the mean cpm of organs of control mice. In animals given LAK cells alone, the lungs and liver demonstrated little if any uptake of SVIUdR above saline-treated controls, whereas the same organs of mice receiving 6000 U of IL 2 alone displayed higher radiolabel incorporation. When mice were given LAK cells plus 6000 U of IL 2, their tissues showed an additional increase in SVIUdR uptake.

Research Organization:
National Cancer Institute, Bethesda, MD
OSTI ID:
6235249
Journal Information:
J. Immunol.; (United States), Journal Name: J. Immunol.; (United States) Vol. 5; ISSN JOIMA
Country of Publication:
United States
Language:
English

Similar Records

Immunotherapy of murine sarcomas using lymphokine activated killer cells: optimization of the schedule and route of administration of recombinant interleukin-2
Journal Article · Sun Jun 01 00:00:00 EDT 1986 · Cancer Res.; (United States) · OSTI ID:5559978

In vivo administration of interferon alpha and interleukin 2 induces proliferation of lymphoid cells in the organs of mice
Journal Article · Sat Sep 01 00:00:00 EDT 1990 · Cancer Research; (USA) · OSTI ID:6528824

Anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo
Journal Article · Mon Jul 01 00:00:00 EDT 1985 · J. Immunol.; (United States) · OSTI ID:6378873